![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Riesinger, Lisa; Strobl, Claudia; Leistner, David M.; Gori, Tommaso; Akin, Ibrahim; Mehr, Michael; Kellnar, Antonia; Mahabadi, Amir A.; Bogossian, Harilaos; Block, Michael; Edelmann, Frank; Sarafoff, Nikolaus; Sibbing, Dirk; Ince, Hüseyin; Rassaf, Tienush; Mansmann, Ulrich 
ORCID: https://orcid.org/0000-0002-9955-8906; Mehilli, Julinda; Kääb, Stefan; Hausleiter, Jörg; Massberg, Steffen und Wakili, Reza
(2021):
Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF). Rationale and design of the prospective randomized parallel-group, open-label, blinded-endpoint, superiority, multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting.
In: IJC Heart & Vessels, Bd. 35, 100810
[PDF, 569kB]
ORCID: https://orcid.org/0000-0002-9955-8906; Mehilli, Julinda; Kääb, Stefan; Hausleiter, Jörg; Massberg, Steffen und Wakili, Reza
(2021):
Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF). Rationale and design of the prospective randomized parallel-group, open-label, blinded-endpoint, superiority, multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting.
In: IJC Heart & Vessels, Bd. 35, 100810
[PDF, 569kB]
Riesinger, Lisa; Strobl, Claudia; Leistner, David M.; Gori, Tommaso; Akin, Ibrahim; Mehr, Michael; Kellnar, Antonia; Mahabadi, Amir A.; Bogossian, Harilaos; Block, Michael; Edelmann, Frank; Sarafoff, Nikolaus; Sibbing, Dirk; Ince, Hueseyin; Rassaf, Tienush; Mansmann, Ulrich; Mehilli, Julinda; Kaeaeb, Stefan; Hausleiter, Joerg; Massberg, Steffen und Wakili, Reza
(2021):
Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF) Rationale and design of the prospective randomized parallel-group, open-label, blinded-endpoint, superiority, multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting.
In: Ijc Heart & Vasculature, Bd. 35, 100810
Willems, Stephan; Tilz, Roland Richard; Steven, Daniel; Kääb, Stefan; Wegscheider, Karl; Geller, Laszlo; Meyer, Christian; Heeger, Christian-Hendrik; Metzner, Andreas; Sinner, Moritz F.; Schlüter, Michael; Nordbeck, Peter; Eckardt, Lars; Bogossian, Harilaos; Sultan, Arian; Wenzel, Beate und Kuck, Karl-Heinz
(2020):
Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT) A Multicenter Randomized Trial.
In: Circulation, Bd. 141, Nr. 13: S. 1057-1067
Bogossian, Harilaos; Frommeyer, Gerrit; Hochadel, Matthias; Ince, Huseyin; Spitzer, Stefan G.; Eckardt, Lars; Maier, Sebastian K. G.; Kleemann, Thomas; Brachmann, Johannes; Stellbrink, Christoph; Gonska, Bernd-Dieter; Kääb, Stefan; Senges, Jochen und Lemke, Bernd
(2019):
Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry.
In: Clinical Research in Cardiology, Bd. 109, Nr. 7: S. 911-917